The effect of dalargin on the level of corticosterone in rats with different individual typological features of behavior in the PTSD model

Capa

Citar

Texto integral

Resumo

The effect of the synthetic analogue of leu-enkephalin (dalargin) on the level of corticosterone in the blood and the mass of the adrenal glands in rats with various typological features of behavior in the model of post-traumatic stress disorder (PTSD) was studied. Groups were formed: active low-anxiety (ALA) and high-anxiety (AHA), as well as passive low-anxiety (PLA) and high-anxiety (PHA) rats. Each of the 4 groups of rats was divided into 3 subgroups, where subgroup 1 is an intact control. 20 days after the first stressful exposure, rats from subgroup 3 were injected intramuscularly with the dalargin for 7 days, and rats from subgroup 2 were injected with the saline solution. It was found that the course of injections of dalargin into rats in the PTSD model had a positive effect on the studied indicators only in the group of active highly-anxiety animals.

Texto integral

Acesso é fechado

Sobre autores

O. Semenova

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences

Autor responsável pela correspondência
Email: Pritvorovaav@infran.ru
Rússia, 199034, St. Petersburg, Makarova emb., 6

A. Vyushina

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences

Email: Pritvorovaav@infran.ru
Rússia, 199034, St. Petersburg, Makarova emb., 6

A. Pritvorova

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences

Email: Pritvorovaav@infran.ru
Rússia, 199034, St. Petersburg, Makarova emb., 6

S. Pivina

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences

Email: Pritvorovaav@infran.ru
Rússia, 199034, St. Petersburg, Makarova emb., 6

N. Ordyan

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences

Email: Pritvorovaav@infran.ru
Rússia, 199034, St. Petersburg, Makarova emb., 6

Bibliografia

  1. Волошин В. М. Посттравматическое стрессовое расстройство. М: Анахарсис, 2005. 200 с.
  2. Лишманов Ю. Б., Маслов Л. Н., Нарыжная Н. В., Пей Ж.-М., Колар Ф., Жанг И., Портниченко А. Г., Ванг Х. Эндогенная опиоидная система как звено срочной и долговременной адаптации организма к экстремальным воздействиям. Перспективы клинического применения опиоидных пептидов // Вестник РАМН. 2012. № 6. С. 73–82.
  3. Семенова О. Г., Вьюшина А. В., Притворова А. В., Ракицкая В. В., Ордян Н. Э. Влияние даларгина на изменение тревожности у крыс с различными индивидуально-типологическими особенностями поведения в модели ПТСР // Журн. высш. нервн. деят. им. И. П. Павлова. 2021. Т. 71. № 5. С. 680–689. doi: 10.31857/S0044467721050099
  4. Тарабрина Н. В. Практическое руководство по психологии посттравматического стресса. М.: Когито-Центр, 2007. ч. 1–2. 208 с.
  5. Хоженко Е. В. Нейрональные механизмы формирования основных клинических синдромов при посттравматическом стрессовом расстройстве // Клинич. медицина. 2009. Т. 87. № 4. С. 4–9.
  6. Шаляпина В. Г., Вершинина Е. А., Ракицкая В. В., Рыжова Л. Ю., Семенова М. Г., Семенова О. Г. Изменение приспособительного поведения активных и пассивных крыс вистар в водно-иммерсионной модели депрессии // Журн. высш. нервн. деят. им. И. П. Павлова. 2006. Т. 56. № 4. С. 543–547.
  7. Шаляпина В. Г., Шабанов П. Д., Основы нейроэндокринологии. СПб.: Элби-СПб, 2005. 472 с.
  8. Blum K., Modestino E. J., Baron D., Brewer R., Thanos P., Elman I., Badgaiyan R. D., Downs B. W., Bagchi D., McLaughlin T., Bowirrat A., Roy A. K., Gold M. S. Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic // CurrPsychopharmacol. 2021. № 10. P. 86–97. doi: 10.2174/2211556009999210104221215
  9. Brockway D. F., Crowley N. A. Turning the tides on neuropsychiatric diseases: the role of peptides in the prefrontal cortex // Frontiers in Behavioral Neuroscience. 2020. № 14.P. 1–23. doi: 10.3389/fnbeh.2020.588400
  10. Browne C. A., Lucki I. Targeting opioid dysregulation in depression for the development of novel therapeutics // Pharmacology & Therapeutics. 2019. V. 201.P. 51–76. doi: 10.1016/j.pharmthera.2019.04.009
  11. Filliol D., Ghozland S., ChulbaJ., Martin M., Matthes H. W., Simonin F., Befort K., Gavériaux-RuffC., Dierich A., LeMeur M., Valverde O., Maldonado R., Kiefferet B. L. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses // Nat.Genet. 2000. V. 25. № 2. P. 195–200. doi: 10.1038/76061
  12. Richards E. M., Mathews D. C., Luckenbaugh D. A., Ionescu D. F., Machado-Vieira R., Niciu M. J., Duncan W. C., Nolan N. M., Franco-Chaves J.A., Hudzik T., Maciag C., Li Sh., Cross A., Smith M. A., Zarate C. A. A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression // Psychopharmacology (Berl). 2016. V. 233. № 6. P. 1119–1130. doi: 10.1007/s00213-015-4195-4
  13. Schmidt U., Kaltwasser S. F., Wotjak C. T. Biomarkers in Posttraumatic Stress Disorder: Overview and Implications for Future Research // Disease Markers. 2013. V. 35. № 1. P. 43–54. doi: 10.1155/2013/835876
  14. Szklarczyk K., Korostynski M., Cieslak P. E., Wawrzczak-Bargielaa A., Przewlocki R. Opioid-dependent regulation of high and low fear responses in two inbred mouse strains // Behavioural Brain Research. 2015. № 292. P. 95–101. doi: 10.1016/j.bbr.2015.06.001
  15. Tseilikman V., Akulov A., Shevelev O., Khotskina A., Kontsevaya G., Moshkin M., Fedotova J., Pashkov A., Tseilikman O., Agletdinov E., Tseilikman D., Kondashevskaya M., Zavjalov E. Paradoxical anxiety level reduction in animal chronic stress: a unique role of hippocampus neurobiology // Int. J. Mol. Sci. 2022. V. 23. P. 91–51. doi: 10.3390/ijms23169151
  16. Wilson C. B., McLaughlin L. D., Nair A., Ebenezer Ph.J., Dange R., Francis J. Inflammation and Oxidative Stress Are Elevated in the Brain, Blood, and Adrenal Glands during the Progression of Post-Traumatic Stress Disorder in a Predator Exposure Animal Model // PloS ONE. 2013. V. 8. № 10. doi: 10.1371/journal.pone.0076146

Declaração de direitos autorais © Russian Academy of Sciences, 2024

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies